Clinical trial
A Large US Health Insurance Claims Database Will be Used to Estimate the Incidence of Serious Outcomes in Patients With Psoriasis Treated With Ustekinumab and Other Types of Biological and Systemic Non-biological Treatments
NCT01081730 is registered in ClinicalTrials.gov with Janssen Biotech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Large US Health Insurance Claims Database Will be Used to Estimate the Incidence of Serious Outcomes in Patients With Psoriasis Treated With Ustekinumab and Other Types of Biological and Systemic Non-biological Treatments
- Lead sponsor
- Janssen Biotech, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 9, 2010
- Completion date
- September 29, 2017
- Enrollment
- 2,040 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.